[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT8467283A0 - OSMOTIC DEVICE HAVING DUAL THERMODYNAMIC ACTIVITY FOR THE CONTROLLED SPEED DELIVERY OF A SUBSTANCE, PARTICULARLY A DRUG, TO THE ENVIRONMENT FOR WHICH IT IS INTENDED - Google Patents

OSMOTIC DEVICE HAVING DUAL THERMODYNAMIC ACTIVITY FOR THE CONTROLLED SPEED DELIVERY OF A SUBSTANCE, PARTICULARLY A DRUG, TO THE ENVIRONMENT FOR WHICH IT IS INTENDED

Info

Publication number
IT8467283A0
IT8467283A0 IT8467283A IT6728384A IT8467283A0 IT 8467283 A0 IT8467283 A0 IT 8467283A0 IT 8467283 A IT8467283 A IT 8467283A IT 6728384 A IT6728384 A IT 6728384A IT 8467283 A0 IT8467283 A0 IT 8467283A0
Authority
IT
Italy
Prior art keywords
drug
substance
environment
intended
controlled speed
Prior art date
Application number
IT8467283A
Other languages
Italian (it)
Other versions
IT8467283A1 (en
IT1178911B (en
Inventor
Brian Barclay Joseph C Deters
Patrick S L Wong Feli Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT8467283(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of IT8467283A0 publication Critical patent/IT8467283A0/en
Publication of IT8467283A1 publication Critical patent/IT8467283A1/en
Application granted granted Critical
Publication of IT1178911B publication Critical patent/IT1178911B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IT8467283A 1983-05-11 1984-03-23 OSMOTIC DEVICE HAVING TWO THERMODYNAMIC ACTIVITIES FOR THE CONTROLLED SPEED DELIVERY OF A SUBSTANCE, PARTICULARLY A DRUG TO THE ENVIRONMENT TO WHICH IT IS INTENDED IT1178911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (3)

Publication Number Publication Date
IT8467283A0 true IT8467283A0 (en) 1984-03-23
IT8467283A1 IT8467283A1 (en) 1985-09-23
IT1178911B IT1178911B (en) 1987-09-16

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8467283A IT1178911B (en) 1983-05-11 1984-03-23 OSMOTIC DEVICE HAVING TWO THERMODYNAMIC ACTIVITIES FOR THE CONTROLLED SPEED DELIVERY OF A SUBSTANCE, PARTICULARLY A DRUG TO THE ENVIRONMENT TO WHICH IT IS INTENDED

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES8503503A1 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
DK0542926T3 (en) * 1990-08-07 1995-05-15 Pfizer Use of interface polymerized membranes in release devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
JP2701977B2 (en) * 1990-09-28 1998-01-21 ファイザー インク Dosage form containing hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
DE69426997T2 (en) * 1993-02-23 2001-11-15 Heikki Sirkkola The use of a calcium preparation in a medicament for the treatment of dairy cows suffering from hypocalcemia
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
KR101167465B1 (en) * 2000-10-30 2012-07-27 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
JP5416408B2 (en) 2005-10-04 2014-02-12 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 5-chloro-N-({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidine-5-yl} -methyl) -2- Novel polymorphs and amorphous forms of thiophenecarboxamide.
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
KR20140069381A (en) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 Sustained release dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
BR112014027618A2 (en) 2012-05-07 2017-06-27 Bayer Pharma AG A process for the manufacture of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil.
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
JOP20210019A1 (en) 2018-07-24 2021-01-24 Bayer Ag Pharmaceutical dosage form which can be administered orally and has modified release
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
CA3107174A1 (en) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
IL71727A0 (en) 1984-09-30
GB8334189D0 (en) 1984-02-01
DK163910B (en) 1992-04-21
IE840010L (en) 1984-11-11
GB2140687A (en) 1984-12-05
CA1222950A (en) 1987-06-16
NL192250B (en) 1996-12-02
NZ206600A (en) 1987-01-23
NO170834C (en) 1992-12-16
AU2251183A (en) 1984-11-15
IT8467283A1 (en) 1985-09-23
SE8402512L (en) 1984-11-12
SE8402512D0 (en) 1984-05-09
DK99784A (en) 1984-11-12
NL8401470A (en) 1984-12-03
ES532018A0 (en) 1985-03-01
FR2545721B1 (en) 1987-11-06
ES8503503A1 (en) 1985-03-01
DE3417113C2 (en) 1989-02-02
DK99784D0 (en) 1984-02-24
JPH0575725B2 (en) 1993-10-21
SE455918B (en) 1988-08-22
DE3417113A1 (en) 1984-11-15
JPS6041609A (en) 1985-03-05
AT397180B (en) 1994-02-25
MX163518B (en) 1992-05-25
IE56515B1 (en) 1991-08-28
NO840248L (en) 1984-11-12
CH669329A5 (en) 1989-03-15
NL192250C (en) 1997-04-03
IL71727A (en) 1989-01-31
BE898819A (en) 1984-05-30
DK163910C (en) 1992-09-14
ATA88084A (en) 1993-07-15
FR2545721A1 (en) 1984-11-16
IT1178911B (en) 1987-09-16
GB2140687B (en) 1987-03-18
ZA842422B (en) 1984-11-28
NO170834B (en) 1992-09-07
AU566110B2 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
IT8467283A0 (en) OSMOTIC DEVICE HAVING DUAL THERMODYNAMIC ACTIVITY FOR THE CONTROLLED SPEED DELIVERY OF A SUBSTANCE, PARTICULARLY A DRUG, TO THE ENVIRONMENT FOR WHICH IT IS INTENDED
IT8267184A0 (en) BANDAGE FOR THE ADMINISTRATION OF MEDICINES
ES549639A0 (en) OSMOTIC DEVICE FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT TO A USE ENVIRONMENT
IT1128094B (en) CATHETER FOR INTERMITTENT MEDICAMENT EN DOVENOUS ADMINISTRATION
IT1185795B (en) DISPENSING DEVICE FOR THE CONTROLLED ADMINISTRATION OF A BENEFICIAL AGENT, PARTICULARLY OF A DRUG WITH RUMINANTS
IT8322832A0 (en) DEVICE FOR THE CONTROLLED ADMINISTRATION OF DRUGS.
NL192430B (en) Pharmaceutical preparation for delayed administration of potassium.
PT88404A (en) DOSAGE FORM COMPRISING FAST AGENT DELIVERY FOLLOWED BY SLOW AGENT DELIVERY
NL195004B (en) Pharmaceutical preparation containing phenyl carbamate.
IT1188095B (en) OSMOTIC DEVICE INCLUDING MEANS TO ADJUST THE INITIAL DURATION OF A MEDICINAL AGENT FROM THAT DEVICE
IT1195817B (en) CONTROLLED SALE DEVICE FOR THE ADMINISTRATION OF A BENEFICIAL AGENT TO A RECEPTOR
IT8622683A0 (en) THERAPEUTIC DEVICE FOR THE ADMINISTRATION OF MEDICINES.
DE68914344D1 (en) Immune suppressant compounds.
IT1047937B (en) COMPOSITION FOR THE GRADUAL TRANSFER OF A MEDICATION
DE3480599D1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING 1-HYDROXYPYRIDE-2-ON DERIVATIVES.
NO863029D0 (en) PHARMACEUTICAL DOSAGE UNIT.
ES552145A0 (en) MANUFACTURING PROCEDURE OF A DOSING UNIT FOR THE ORAL ADMINISTRATION OF POTASSIC CHLORIDE.
DE3672492D1 (en) LIQUID CRYSTALLINE ISOTHIOCYANATE DERIVATIVES.
IT1170728B (en) DEVICE FOR THE ADMINISTRATION OF MEDICALLY SUBSTANCES
IT1179843B (en) OSMOTIC DEVICE AND PROCEDURE FOR THE DISPENSING OF A BENEFICIAL AGENT, PARTICULARLY OF A DRUG TO A USER ENVIRONMENT
IT1213080B (en) THERAPEUTIC SYSTEMS FOR THE CONTROLLED SALE OF DRUGS.
IT8421874A0 (en) ORAL SOLID PHARMACEUTICAL FORM WITH SEQUENTIAL ACTION FOR THE ADMINISTRATION OF DRUGS WITH ULCEROGENIC SIDE EFFECTS.
IT7822316A0 (en) PHARMACEUTICAL COMPOSITION FOR THE ADMINISTRATION OF PANCREATIN.
ES509234A0 (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTEPAL DOSING UNIT.
IT8722647A0 (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19980327